EXACT Sciences Valuation
| EXAS Stock | USD 71.34 1.61 2.21% |
At this time, the firm appears to be undervalued. EXACT Sciences owns a latest Real Value of $81.89 per share. The recent price of the firm is $71.34. Our model computes the value of EXACT Sciences from analyzing the firm fundamentals such as Shares Outstanding of 181.53 M, current valuation of 13.65 B, and Return On Asset of -0.0304 as well as examining its technical indicators and probability of bankruptcy. In general, most investors advise acquiring undervalued equities and selling overvalued equities since, in the future, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting EXACT Sciences' valuation include:
Price Book 4.1191 | Enterprise Value 13.7 B | Enterprise Value Ebitda 503.1228 | Price Sales 5.1807 | Enterprise Value Revenue 5.8937 |
Undervalued
Today
Please note that EXACT Sciences' price fluctuation is very steady at this time. Calculation of the real value of EXACT Sciences is based on 3 months time horizon. Increasing EXACT Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for EXACT Sciences is useful when determining the fair value of the EXACT stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of EXACT Sciences. Since EXACT Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EXACT Stock. However, EXACT Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 71.34 | Real 81.89 | Target 106.38 | Hype 71.47 |
The real value of EXACT Stock, also known as its intrinsic value, is the underlying worth of EXACT Sciences Company, which is reflected in its stock price. It is based on EXACT Sciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of EXACT Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EXACT Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of EXACT Sciences helps investors to forecast how EXACT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EXACT Sciences more accurately as focusing exclusively on EXACT Sciences' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use EXACT Sciences' intrinsic value based on its ongoing forecasts of EXACT Sciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against EXACT Sciences' closest peers. When choosing an evaluation method for EXACT Sciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
EXACT Sciences Investments |
|
EXACT Valuation Trend
Knowing EXACT Sciences' actual value is paramount for traders to make sound investment determinations. EXACT Sciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of EXACT Sciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both EXACT Sciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
EXACT Market Cap
EXACT Sciences is rated # 5 in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 495.13 Billion. EXACT Sciences holds roughly 12.96 Billion in market capitalization claiming about 2.62% of equities under Health Care industry.EXACT Sciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining EXACT Sciences's current stock value. Our valuation model uses many indicators to compare EXACT Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EXACT Sciences competition to find correlations between indicators driving EXACT Sciences's intrinsic value. More Info.EXACT Sciences is rated below average in price to earning category among related companies. It is rated # 5 in price to book category among related companies . Price To Book Ratio is likely to gain to 4.47 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value EXACT Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for EXACT Sciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EXACT Sciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates EXACT Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in EXACT Sciences and how it compares across the competition.
About EXACT Sciences Valuation
The stock valuation mechanism determines the current worth of EXACT Sciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of EXACT Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of EXACT Sciences based exclusively on its fundamental and basic technical indicators. By analyzing EXACT Sciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of EXACT Sciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of EXACT Sciences. We calculate exposure to EXACT Sciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to EXACT Sciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.8 B | 1.9 B | |
| Pretax Profit Margin | (0.08) | (0.08) | |
| Operating Profit Margin | (0.09) | (0.09) | |
| Net Loss | (0.08) | (0.09) | |
| Gross Profit Margin | 0.74 | 0.76 |
8 Steps to conduct EXACT Sciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates EXACT Sciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct EXACT Sciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain EXACT Sciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine EXACT Sciences' revenue streams: Identify EXACT Sciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research EXACT Sciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish EXACT Sciences' growth potential: Evaluate EXACT Sciences' management, business model, and growth potential.
- Determine EXACT Sciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate EXACT Sciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
EXACT Sciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as EXACT Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 180.1 M |
EXACT Sciences Current Valuation Indicators
Valuation refers to the process of determining the present value of EXACT Sciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value EXACT we look at many different elements of the entity such as EXACT's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. EXACT Sciences' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final EXACT Sciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as EXACT Sciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use EXACT Sciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes EXACT Sciences' worth.When determining whether EXACT Sciences is a strong investment it is important to analyze EXACT Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EXACT Sciences' future performance. For an informed investment choice regarding EXACT Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for EXACT Stock analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.13) | Revenue Per Share 13.876 | Quarterly Revenue Growth 0.17 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.